Lexeo Therapeutics Balance Sheet (2022-2023) | LXEO

Balance Sheet Sep2022 Dec2022 Sep2023
Assets
Current Assets
Cash & Equivalents 94.15M77.33M35.45M
Cash & Current Investments 94.15M77.33M35.45M
Prepaid Assets 2.34M2.01M
Current Assets 80.05M38.87M
Non-Current Assets
Property, Plant & Equipment (Net) 1.00M0.98M
Other Non-Current Assets 3.25M3.25M3.25M
Non-Current Assets 17.03M15.85M
Assets 97.08M54.72M
Liabilities
Current Liabilities
Accounts Payables 2.68M2.65M
Notes Payables 4.15M
Payables 2.68M6.80M
Accumulated Expenses 6.42M11.80M
Other Accumulated Expenses 0.24M0.18M
Current Leases 2.29M2.08M
Current Taxes 0.51M0.02M
Total Current Liabilities 14.35M23.04M
Non-Current Liabilities
Capital Leases 1.65M1.35M
Preferred Stock Liabilities 185.03M185.03M185.03M
Operating Leases 9.00M8.11M
Other Non-Current Liabilities 4.27M
Total Non-Current Liabilities 28.23M
Total Liabilities 25.00M32.50M
Shareholder's Equity
Common Equity -98.98M-112.95M-162.81M
Shareholder's Equity -98.98M-112.95M-162.81M
Liabilities and Shareholders Equity 97.08M54.72M
Retained Earnings -115.45M-167.65M